PRESS-RELEASE ·Filed Oct 2, 2026
Press release · Activist
Actionable Insight • Neutral
Monitor upcoming quarterly filings for any changes in share count or R&D pipeline updates; this grant alone does not alter the company's outlook.
Latest settled — T+5d
NTLA ▼ -1.33% at T+5d
NEUTRAL call -1.33% · α vs SPY -1.76% · entry $12.75 → $12.58
Latest observation: T+14 +1.61% FF3 residual α
T+1d
-2.98%
call -2.98% · α -3.53%
$12.37
settled 21d ago
T+5d
-1.33%
call -1.33% · α -1.76%
$12.58
settled 17d ago
T+20d
Pending
in 4d
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
Intellia Therapeutics granted inducement stock awards to eight new employees under its 2024 Inducement Plan. This is a routine equity grant to attract talent and has no material impact on the company's financials or pipeline.
Key Facts
- Inducement grants awarded to eight new employees on October 1, 2026.
- Grants made under the 2024 Inducement Plan as a material inducement to employment.
Financial Impact
Undisclosed amount; routine equity compensation for new hires.
dilution
Risk Factors
- No material risks identified from this filing.
Investment Themes
Biotech & Drug DiscoveryGenomics & Gene Editing
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3374008 |
15 reports for NTLA
50% Hit rate @ T+5 Went positive at some point 4 of 6 best @ T+60▲ +15.91%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 2, 2026 23d ago | Press Release | $12.75 $12.58 | ▼ −1.33% | ▼ −1.76% | $11.23 (−11.92%) |
Sep 8, 2026 6w ago | 8-K | $12.21 $11.60 | ▼ −5.00% | ▼ −4.66% | $11.23 (−8.03%) |
Aug 6, 2026 11w ago | 8-K | $11.24 $11.83 | ▲ +5.25% | ▲ +4.04% | $11.23 (−0.09%) |
Jun 15, 2026 19w ago | 8-K | $14.92 $15.75 | ▲ +5.56% | ▲ +6.95% | $11.23 (−24.73%) |
Jun 13, 2026 19w ago | Press Release | $14.92 $15.75 | ▲ +5.56% | ▲ +6.95% | $11.23 (−24.73%) |
Jun 1, 2026 21w ago | Press Release | $13.73 $13.54 | ▼ −1.38% | ▲ +1.37% | $11.23 (−18.21%) |
May 11, 2026 24w ago | 8-K | $14.42 $12.69 | ▼ −12.00% | ▼ −11.91% | $11.23 (−22.12%) |
Apr 27, 2026 25w ago | Press Release | $13.20 $13.87 | ▼ −5.08% | ▼ −3.38% | $11.23 (+14.92%) |
Apr 27, 2026 26w ago | 8-K | $13.04 $13.87 | ▲ +6.37% | ▲ +5.96% | $11.23 (−13.88%) |
Apr 3, 2026 29w ago | Press Release | $13.30 $14.26 | ▲ +7.22% | ▲ +3.08% | $11.23 (−15.56%) |
Showing 10 of 15
US Market Status
Market Open — Closes in 5h 19m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers